Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-25-075238
Filing Date
2025-05-20
Accepted
2025-05-20 16:30:56
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 srzn_s-3_shelf_202505.htm S-3 541949
2 EX-4.4 srzn-ex4_4.htm EX-4.4 514450
3 EX-4.6 srzn-ex4_6.htm EX-4.6 216942
4 EX-4.7 srzn-ex4_7.htm EX-4.7 220797
5 EX-4.8 srzn-ex4_8.htm EX-4.8 196362
6 EX-5.1 srzn-ex5_1.htm EX-5.1 47228
7 EX-23.1 srzn-ex23_1.htm EX-23.1 5901
8 EX-FILING FEES srzn-exfiling_fees.htm EX-FILING FEES 58491
9 GRAPHIC img106842253_0.jpg GRAPHIC 29766
10 GRAPHIC img106842253_1.jpg GRAPHIC 29766
11 GRAPHIC img200110477_0.jpg GRAPHIC 27728
12 GRAPHIC img200110477_1.jpg GRAPHIC 27728
  Complete submission text file 0000950170-25-075238.txt   1962264
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

EIN.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-287434 | Film No.: 25969272
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)